多组学分析探索瘢痕疙瘩相关分子机制
本研究通过批量RNA测序、孟德尔随机化、免疫浸润分析、GSEA/GSVA、网络分析和单细胞RNA测序探索瘢痕疙瘩的分子机制。孟德尔随机化显示DUSP1抑制瘢痕疙瘩形成而HOXA5促进其发病,免疫浸润分析提示肥大细胞和巨噬细胞起关键作用,IL17信号通路为关键通路,药物预测模型识别出4种靶向枢纽基因的潜在药物。
要点
- 孟德尔随机化显示DUSP1抑制瘢痕疙瘩形成,HOXA5促进瘢痕疙瘩发病。
- 免疫浸润分析提示肥大细胞和巨噬细胞在瘢痕疙瘩进展中起关键作用。
- IL17信号通路被确定为瘢痕疙瘩发展的关键通路,药物预测模型识别出4种靶向枢纽基因的潜在药物。
核心结论
- DUSP1和HOXA5是瘢痕疙瘩发病的枢纽基因,DUSP1抑制疾病进展而HOXA5促进疾病进展。
- 靶向这些基因相关的调控网络可能提供新的治疗策略。
- 肥大细胞和巨噬细胞被确定为参与疾病过程的关键免疫细胞类型。
- IL17信号通路在瘢痕疙瘩发展中起关键作用,凸显其作为治疗靶点的潜力。
- 这些发现提示聚焦于这些通路的多靶点方法可能为瘢痕疙瘩患者提供有效治疗选择。
研究设计与样本
- 研究采用批量RNA测序分析瘢痕疙瘩组织的基因表达谱,识别差异表达基因并进行通路富集分析。
- 研究进行孟德尔随机化探究遗传因素与瘢痕疙瘩形成的因果关系并识别枢纽基因。
- 研究进行免疫浸润分析确定特定免疫细胞在瘢痕疙瘩发展中的作用。
- 研究进行基因集富集分析(GSEA)和基因集变异分析(GSVA)探究枢纽基因相关的功能通路。
- 研究采用网络分析识别与枢纽基因相关的转录因子、miRNA和Connectivity Map中的潜在药物,并使用单细胞RNA测序识别这些基因的细胞特异性表达模式。
主要发现
- 通路富集分析显示瘢痕疙瘩发病与细胞增殖和分裂相关。
- 孟德尔随机化显示DUSP1作为瘢痕疙瘩形成的抑制剂,而HOXA5促进瘢痕疙瘩发病。
- 免疫浸润分析提示肥大细胞和巨噬细胞在疾病进展中起关键作用。
- 基于枢纽基因分析,IL17信号通路成为瘢痕疙瘩发展的关键通路。
- 药物预测模型识别出9-甲基-5H-6-硫杂-4,5-二氮杂-䓛-6,6-二氧化物、zebularine、temozolomide和valproic acid靶向这些枢纽基因。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Keloid is a benign skin tumor that result from abnormal wound healing and excessive collagen deposition. The pathogenesis is believed to be linked to genetic predisposition and immune imbalance, although the precise mechanisms remain poorly understood. Current therapeutic approaches may not consistently yield satisfactory outcomes and are often accompanied by potential side effects and risks. The high recurrence rate and refractory nature of keloid nodules present significant challenges and uncertainties in their management. Given the lack of effective treatment strategies, it is essential to identify key molecular pathways and potential therapeutic targets for keloid. OBJECTIVE: This study aimed to identify the potential pathogenic mechanisms, hub genes, and immune cell involvement in keloid formation, with the goal of providing novel insights for targeted therapies. METHODS: We utilized a combination of bulk RNA sequencing to analyze gene expression profiles in keloid tissues. Differentially expressed genes (DEGs) were identified and subjected to pathway enrichment analysis to reveal key biological processes involved in keloid pathogenesis. Mendelian randomization was performed to investigate the causal relationship between genetic factors and keloid formation, identifying potential hub genes. Immune infiltration analysis was conducted to determine the role of specific immune cells in keloid development. Subsequently, Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA) were performed to investigate the functional pathways associated with the hub genes. Network analysis was employed to identify transcription factors, miRNAs, and potential drugs in the Connectivity Map associated with the hub genes. Single-cell RNA sequencing was also used to identify cell-specific expression patterns of these genes. RESULTS: Pathway enrichment analysis highlighted the association of keloid pathogenesis with cell proliferation and division, providing insights into the molecular processes involved. Mendelian randomization revealed that DUSP1 acts as an inhibitor of keloid formation, while HOXA5 promotes keloid pathogenesis. Immune infiltration analysis suggested that mast cells and macrophages play critical roles in the disease's progression. Based on hub gene analysis, the IL17 signaling pathway emerged as a key pathway implicated in keloid development. Further drug prediction models identified 9-methyl-5H-6-thia-4, 5-diaza-chrysene-6, 6-dioxide, zebularine, temozolomide and valproic acid targeting these hub genes. CONCLUSION: DUSP1 and HOXA5 are hub genes in keloid pathogenesis, with DUSP1 acting as an inhibitor and HOXA5 as a promoter of disease progression. Targeting the regulatory networks associated with these genes could provide novel therapeutic strategies. Mast cells and macrophages are identified as critical immune cell types involved in the disease process. Additionally, the IL17 signaling pathway plays a crucial role in keloid development, highlighting its potential as a therapeutic target. These findings suggest that a multi-target approach focusing on these pathways could offer effective treatment options for keloid patients.
引用
- Xu H, Li K, Liang X, et al. Multi-omics analysis to explore the molecular mechanisms related to keloid. Burns. 2025. PMID: 39874886. doi:10.1016/j.burns.2025.107396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。